OOIR: Observatory of International Research

Papers

(The median citation count of International Clinical Psychopharmacology is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Immunomodulatory options for neurodevelopmental spectrum conditions: are we there yet?	37
The role of personality traits in following quarantine orders during the COVID-19 pandemic	27
Beyond antipsychotics: the role of medication and nonmedication factors in female sexual dysfunctions in schizophrenia	24
Does the comorbidity of borderline personality disorder affect the response to treatment in bipolar patients?	17
Risperidone combination therapy with adalimumab for treatment of chronic schizophrenia: a randomized, double-blind, placebo-controlled clinical trial	16
Antidepressant psychopharmacology: is inflammation a future target?	16
Sleep disturbance in schizophrenia spectrum disorders: more than just a symptom?	15
Venlafaxine for tramadol dependence and medical cannabis therapy for generalized anxiety disorder	13
Catatonia as a debut of systemic lupus erythematosus: a case report on a diagnostic challenge	12
Clinical specificity profile for novel rapid acting antidepressant drugs	12
Age matters when improving symptoms of anxiety, depression, and sleepiness in patients with obstructive sleep apnea treated with continuous positive airway pressure	12
Open issues in bipolar and antipsychotic treatments	11
Validation of the Spanish version of the multifaceted empathy test: comparison between cannabis use effects and controls in social cognition	10
Case series on aripiprazole and dopamine supersensitivity psychosis	10
Dropped-Head syndrome: a possible new variant of clozapine-induced inflammation during titration	10
Differential effectiveness between Ketamine and Esketamine: the predictive role of dissociative features. A treatment-resistant depression case	10
Doxazosin improved COVID-19 associated nightmare in a patient with major depressive disorder: a case report with a positive rechallenge	10
Remission of treatment-resistant obsessive-compulsive disorder with 600 milligrams of fluvoxamine daily: a case report	10
Managing depression in the elderly: real-world clinical considerations and perspectives	10
Persistence of suicidal ideation within acute phase treatment of major depressive disorder: analysis of clinical predictors	9
The Gordian knot of the immune-redox systems’ interactions in psychosis	9
Towards a replicable protocol to identify patients with psychiatric disorders at higher risk of developing dementia	9
Debated issues in major psychoses	9
Differences in emotion recognition between nonimmersive versus immersive virtual reality: preliminary findings in schizophrenia and bipolar disorder	9
Prospective, comparative, pilot study of maintenance treatment in comorbid bipolar disorders with post-traumatic stress disorder	9

Suicide in prison in the North of Italy (1993–2022): a case-control study examining differences between suicides inside and outside prison	9
Prevalence and correlates of prescription drug abuse and misuse among adult prisoners: a systematic review	8
Elevated liver transaminases among patients with psychiatric disorders	8
The bidirectional interaction between antidepressants and the gut microbiota: are there implications for treatment response?	8
Predictors of long-acting injectable antipsychotic prescription at discharge in patients with schizophrenia and other psychotic disorders	8
Selective serotonin reuptake inhibitors and quality of life: a meta-analysis of randomized placebo-controlled trials	8
Navigating the pharmacologic complexities of QTc prolongation: assessing the cumulative burden in individuals with serious mental illness	7
Modulating factors in mood disorders treatment	7
Effect of sertraline on depression severity and prolactin levels in women with polycystic ovary syndrome: a placebo-controlled randomized trial	7
Innovation in psychopharmacology	7
Repeated subcutaneous racemic ketamine in treatment-resistant depression: case series	7
Immediate-release vs. prolonged-release lithium formulations in bipolar disorder: a 2-year comparative study	7
Vitamin E in the treatment of tardive dyskinesia: a meta-analysis	7
Case report and systematic review of cerebellar vermis alterations in psychosis	7
Treatment adherence in forensic patients with schizophrenia spectrum disorders discharged on long-acting injectable antipsychotics: a comparative 3-year mirror-image study	6
Cariprazine: an augmentation strategy for treatment-resistant schizophrenia with pro-cognitive and anti-hostility effects	6
Allergic reaction induced by subcutaneous administration of ketamine: a case report	6
Interplay of environmental and clinical factors in psychiatric disorders	6
Obsessive-compulsive symptoms in major depressive disorder correlate with clinical severity and mixed features	6
The impact of mild behavioral impairment on the prognosis of geriatric depression: preliminary results	6
Systematic literature review and network meta-analysis of lurasidone, brexpiprazole and cariprazine for schizophrenia	6
Efficacy and safety of lurasidone in schizophrenia: pooled analysis of European results from double-blind, placebo-controlled 6-week studies	6
Long-term remission following esketamine nasal spray sessions in a patient with severe and highly treatment-resistant depression: a single-case report	5
Patterns of antipsychotic prescription and accelerometer-based physical activity levels in people with schizophrenia spectrum disorders: a multicenter, prospective study	5
Cilostazol as adjunctive therapy in treatment of children with autism spectrum disorders: a double-blind and placebo-controlled randomized trial	5
Manic episode in a patient with pancreatic adenocarcinoma: a case report	5
Increased risk of death compared to other antipsychotics in elderly clozapine users in Poland	5
The challenge of managing difficult to treat psychiatric conditions	5
Advances in the treatment of depression	5
Treatment adherence and tolerability of immediate- and prolonged-release lithium formulations in a sample of bipolar patients: a prospective naturalistic study	5
Hyperthyroidism and depression: a clinical case of atypical thyrotoxicosis manifestation	4
Mental health in patients affected by atopic dermatitis: which effects of treatment with dupilumab?	4
Intravenous trazodone for the treatment of psychomotor agitation and associated symptoms in major depressive disorder patients experiencing a depressive episode with mixed features	4
QT prolongation is over-estimated by Bazett compared to Friderica in Japanese child and adolescent inpatients	4
Differentiating the third generation of antipsychotics: a focus on lumateperone’s similarities and differences	4
The effect of crocin versus sertraline in treatment of mild to moderate postpartum depression: a double-blind, randomized clinical trial	4
Persian translation and validation of community attitudes toward the mentally ill scale: a tool for assessing social stigma about mental illness	4
The potential use of daridorexant in eating disorders: beyond the treatment of insomnia?	4
Capillary blood sampling for the determination of clozapine concentrations: analytical validation and patient experience	4
Lithium toxicity at therapeutic doses as a fallout of COVID-19 infection: a case series and possible mechanisms	4
The relationship between mobile phone addiction and depression, anxiety, and sleep quality in medical students	4
Pharmacological and philosophical considerations for the around-the-clock use of scheduled melatonin to promote sedation and reduce aggression in individuals with serious mental illness: a case report	4
Impact of long-acting injectable aripiprazole on the concomitant medication and antipsychotic polypharmacy: a retrospective, observational study of 127 patients with psychosis	4
Associations of adolescent psychosocial factors to later benzodiazepine use: a population-based follow-up study of adolescent psychiatric inpatients in Northern Finland	3
Cariprazine as a maintenance treatment in dual schizophrenia: a 6-month observational study in patients with schizophrenia and cannabis use disorder	3
The efficacy of escitalopram in major depressive disorder: a multicenter randomized, placebo-controlled double-blind study	3
Lurasidone in first-episode psychosis with predominant depressive symptoms: a case report	3
Vortioxetine improves cognition in mild cognitive impairment	3
Aripiprazole: examining the clinical implications of D2 affinity	3
Clinical and demographic factors associated with early relapse in patients with schizophrenia: a naturalistic observation study	3

In search of clinical targets for suicide prevention in major depressive disorder	3
The effect of early or late initiation of long-acting antipsychotics on the caregiver burden in schizophrenia	3
Sex-controlled differences in sertraline and citalopram efficacies in major depressive disorder: a randomized, double-blind trial	3
Efficacy and safety of adjunctive therapy with lumateperone in major depressive disorder: a randomized-, double-blind, placebo-controlled clinical trial	3
Catatonic postpartum paternal depression as a first debut of a bipolar disorder: a case report	3
Frequency, risk factors, and impacts on quality of life of the restless legs syndrome and side effects among antidepressant users in a tertiary hospital: an observational cross-sectional study	3
Brexpiprazole augmentation in treatment-resistant obsessive-compulsive disorder: a preliminary retrospective observational study	3
The P300 component of the auditory event-related potential in adult psychiatric and neurologic disorders: a narrative review of clinical and experimental evidence	3
Does tramadol dependence impair cognitive functions?	3
Evaluating the influence of nonproblematic alcohol intake on the outcome of major depression	3
Acceptability of transdermal antipsychotic patches by patients who refuse oral medication and their effectiveness in preventing recurrence of delirium: a retrospective observational study	3
Crocus sativus (saffron) adjunct to risperidone for negative symptoms of schizophrenia: a randomized, double-blind, placebo-controlled trial	3
An investigation into the association between suicide mortality rate and lithium levels in potable water: a review study	3
Successful clozapine rechallenge after myopericarditis: a case report	3
Diabetes mellitus in patients with chronic bipolar disorder: prevalence, clinical correlates and relationship with homocysteine	3
Tolcapone in obsessive-compulsive disorder: a randomized double-blind placebo-controlled crossover trial	3
Psychometric validation of the Persian version of the Mental Health Knowledge Schedule	3
Dissociative episode and panic attacks triggered by pitolisant in a narcoleptic patient	2
Occurrence of involuntary movements after prolonged misuse of zolpidem: a case report	2
Psychopharmacology: past, present and future	2
DRESS syndrome: quetiapine associated case report and literature review	2
Characteristics and outcomes of cases with methylphenidate abuse, dependence or withdrawal: an analysis of spontaneous reports in EudraVigilance	2
Can bupropion treat COVID-19–induced brain fog? A case series	2
Phosphodiesterase inhibitor and selective serotonin reuptake inhibitor combination therapy versus monotherapy for the treatment of major depressive disorder: a systematic review and meta-analysis	2
Medicare claims analysis of agents used to manage dementia-related psychosis: a treatment pattern study	2
Investigating the psychological effects of home quarantine during the early peaks of the COVID-19 pandemic: a survey from Iran	2
l-carnitine adjunct to risperidone for treatment of autism spectrum disorder-associated behaviors: a randomized, double-blind clinical trial	2
Lurasidone as add-on to fluoxetine in obsessive-compulsive disorder with comorbid restrictive anorexia: a case report	2
Risk of conversion to bipolar disorder in patients with late-onset major depression	2
More must be done to reduce cardiovascular risk for patients on antipsychotic medications	2
Tetrahydrocannabinol fails to reduce hair pulling or skin picking: results of a double-blind, placebo-controlled study of dronabinol	2
Antidepressant drug use and regional prescribing patterns in Germany: results from a large population-based study	2
Trends of complications in patients with Parkinson’s disease in seven major cities of China from 2016 to 2019	2
Clinical experiences with intranasal esketamine for major depressive disorder resistant to treatment and with a psychiatric emergency: case presentations	2
Antidepressants use in Italy: an ecological study of national and regional trends and associated factors	2
Spanish versions and validation of a series of rating scales and visual analogue scales to assess the subjective effects of cannabis	2
Resistance to antidepressant treatment among patients with major depressive disorder: a nationwide study	2
Severe methodological problems in a recent review and analysis of the association between lithium concentration in potable water and suicide rates	2
Rhabdomyolysis during adjunctive treatment with cariprazine in a clozapine-resistant schizophrenia patient	2
Type 2 diabetes mellitus is associated with manic morbidity in elderly patients with mood disorders	2
Relationship between clinical efficacy and plasma concentration-dose ratio of risperidone in patients with schizophrenia	2
Examining age of onset phenotype in the spectrum of mood disorders	2
Bipolar disorder and Susac syndrome: a case report	2
Antidepressants in the acute treatment of post-traumatic stress disorder in adults: a systematic review and meta-analysis	2
Pharmacologic treatment of depression in Alzheimer’s disease	2
Unleashing the power of pooled and subgroup analyses in psychiatry	2
Clinical correlates and prognostic impact of binge-eating symptoms in major depressive disorder	2
Antidepressant treatment in complex clinical pictures	2
Treatment adherence rates across different psychiatric disorders and settings: findings from a large patient cohort	2
Short-term, but not long-term, beneficial effects of concomitant benzodiazepine use on clinical course in patients with schizophrenia	2
Clinical correlates and prognostic implications of severe suicidal ideation in major depressive disorder	2
Oxcarbazepine versus sodium valproate in treatment of acute mania: a double-blind randomized clinical trial	2
Can levetiracetam improve clinical symptoms in schizophrenic patients? A randomized placebo-controlled clinical trial	2
Ketamine for depression: a potential role in requests for Medical Aid in Dying?	2
Assessment of clinical outcomes in patients with inflammatory arthritis: analysis from the UK Medical Cannabis Registry	2
Remission of functional motor symptoms following esketamine administration in a patient with treatment-resistant depression: a single-case report	2